Home / Companies / Astellas Pharma, Inc. / 19 Jun 2026
Astellas Pharma, Inc.: meeting of 19 Jun 2026
Votes reported on Form N-PX, item by item
160 Form N-PX filers reported votes at the Astellas Pharma, Inc. meeting of 19 Jun 2026. Their records fall into 2 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
10 nominees; 90.1% of reported votes for; 110 filers withheld from or voted against at least one nominee.
3,441 vote records from 159 filers. 5 of the 156 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
18 vote records from 11 filers. No filer marked a management recommendation, so no against-management figure is reported. 11 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors |
|---|---|
| Vanguard | For |
| BlackRock and iShares | For |
| Fidelity | For |
| Dimensional | For |
| State Street and SPDR | For |
| American Century | For |
| Franklin Templeton | For |
| Invesco | For |
| Equitable | For |
| Charles Schwab | For |
| Nuveen and TIAA | For |
| ProShares and ProFunds | Split or no vote |
| John Hancock and Manulife | For |
| Morgan Stanley, Eaton Vance and Calvert | For |
| J.P. Morgan | For |
| Goldman Sachs | For |
| WisdomTree | For |
| PGIM and Prudential | For |
| Jackson National funds | For |
| Northern Trust and FlexShares | For |
| SEI | For |
| T. Rowe Price | For |
| Thrivent | For |
| Lincoln Financial | For |
| Voya | For |
| First Trust | For |
| Russell Investments | For |
| Nationwide | For |
| Victory Capital | For |
| Brighthouse Funds | For |
| Columbia Threadneedle | For |
| BNY Mellon | For |
| Principal | For |
| Global X | For |
| MFS | For |
| Transamerica | For |
| AllianceBernstein | For |
| Hartford Funds | For |
| DWS | For |
| PIMCO | For |
| Allspring | For |
| Harbor Funds | For |
| Virtus | For |
| Neuberger Berman | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Astellas Pharma, Inc. meeting?
160 Form N-PX filers reported votes at the meeting of 19 Jun 2026. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Astellas Pharma, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Astellas Pharma, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Astellas Pharma, Inc. with a meeting date within three days of 19 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.